[PDF][PDF] Procoagulant activity during viral infections

S Subramaniam, I Scharrer - Front Biosci (Landmark Ed), 2018 - article.imrpress.com
Introduction 2.1. Tissue Factor (TF)-dependent activation of coagulation system 2.2.
Endothelial cells (ECs) directed Hemostasis 2.3. Virus life cycle 2.4. TLRs expression …

Biology of portal hypertension

M McConnell, Y Iwakiri - Hepatology international, 2018 - Springer
Portal hypertension develops as a result of increased intrahepatic vascular resistance often
caused by chronic liver disease that leads to structural distortion by fibrosis, microvascular …

Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis

S Petta, LE Adinolfi, AL Fracanzani, F Rini… - Journal of …, 2018 - Elsevier
Background and Aims Recent studies suggest an association between hepatitis C virus
(HCV) infection and cardiovascular damage, including carotid atherosclerosis, with a …

[HTML][HTML] Changes of gut-microbiota-liver axis in hepatitis C virus infection

M El-Mowafy, A Elgaml, M El-Mesery, S Sultan… - Biology, 2021 - mdpi.com
The gut–liver-axis is a bidirectional coordination between the gut, including microbial
residents, the gut microbiota, from one side and the liver on the other side. Any disturbance …

Short and long-term postoperative complications following total joint arthroplasty in patients with human immunodeficiency virus, hepatitis B, or hepatitis C

BJ Kildow, CS Politzer, M DiLallo, MP Bolognesi… - The Journal of …, 2018 - Elsevier
Introduction Due to advancement in treatment against human immunodeficiency virus (HIV),
hepatitis B virus (HBV), and hepatitis C virus (HCV), the prevalence of this patient population …

[HTML][HTML] Hepatitis C virus and cardiovascular: A review

S Petta - Journal of advanced research, 2017 - Elsevier
Chronic hepatitis C virus (HCV) infection is a systemic disease that leads to increased risks
of cirrhosis and its complications, as well as extrahepatic disturbances, including immune …

Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients

LM Medrano, P Garcia-Broncano, J Berenguer… - Aids, 2018 - journals.lww.com
Objectives: Immune dysregulation is a hallmark of HIV and hepatitis C virus (HCV)
infections. We aimed to evaluate the relationship between liver stiffness measurement (LSM) …

Evaluation of cardiovascular risk factors after hepatitis C virus eradication with direct-acting antivirals in a cohort of treatment-naïve patients without history of …

D Casas-Deza, A Martínez-Sapiña, S Espina… - Journal of Clinical …, 2022 - mdpi.com
Background: Hepatitis C virus (HCV) produces changes at multiple levels in host
metabolism, especially in lipid profile and cardio-metabolic risk. It is unclear how HCV …

The effect of viral clearance achieved by direct-acting antiviral agents on hepatitis C virus positive patients with type 2 diabetes mellitus: a word of caution after the …

DG Ribaldone, M Sacco, GM Saracco - Journal of clinical medicine, 2020 - mdpi.com
The causal link between chronic hepatitis C and glycometabolic alterations has been
confirmed by much biochemical, clinical, and epidemiological research work, but what is still …

Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells

E Grossini, C Smirne, S Venkatesan, S Tonello… - International Journal of …, 2023 - mdpi.com
Hepatitis C virus (HCV) patients are at increased risk of cardiovascular disease (CVD). In
this study, we aimed to evaluate the role of extracellular vesicles (EVs) as pathogenic factors …